Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Aboagyewaah Oppong-Damoah"'
Publikováno v:
Heliyon, Vol 5, Iss 6, Pp e01915- (2019)
Approximately 20 million adults in the United States have an alcohol use disorder. In recent years, modulation of the behavioral effects of ethanol by phytochemicals has been explored. In this study, we used the ethanol-induced loss of righting refle
Externí odkaz:
https://doaj.org/article/7fbc7ff3901943cfb332ac0f8265e086
Autor:
Aboagyewaah Oppong-Damoah, Kevin S. Murnane, Bruce E. Blough, Kristen E Curry, Kenner C. Rice
Publikováno v:
Psychopharmacology (Berl)
RATIONALE: Approximately 20 million adults in the United States have an alcohol use disorder (AUD). There are clinical and preclinical data suggesting that psychedelics may have benefits for AUD. OBJECTIVE: To investigate the effects of the synthetic
Publikováno v:
CNSneurological disorders drug targets. 21(1)
Alcohol-use disorder (AUD) remains a major public health concern. In recent years, there has been a heightened interest in components of the endocannabinoid system for the treatment of AUD. Cannabinoid type 1 (CB1) receptors have been shown to modula
Publikováno v:
Heliyon, Vol 5, Iss 6, Pp e01915-(2019)
Heliyon
Heliyon
Approximately 20 million adults in the United States have an alcohol use disorder. In recent years, modulation of the behavioral effects of ethanol by phytochemicals has been explored. In this study, we used the ethanol-induced loss of righting refle
Autor:
J. Phillip Bowen, Kalyn M. Rambacher, Osman F. Guner, Cedrick Maceo Daphney, Aboagyewaah Oppong-Damoah, Kevin S. Murnane, Nader H. Moniri, Tyler J. Murphy, Kenner C. Rice
Publikováno v:
Pharmacol Biochem Behav
There is increasing support for the potential clinical use of compounds that interact with serotonin 2A (5-HT(2A)) receptors. It is therefore of interest to discover novel compounds that interact with 5-HT(2A) receptors. In the present study, we used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b354d07de144c1458ffaf13c302a4f2
https://europepmc.org/articles/PMC6570414/
https://europepmc.org/articles/PMC6570414/
The blood-brain barrier (BBB) limits the therapeutic use of large molecules as it prevents them from passively entering the brain following administration by conventional routes. It also limits the capacity of researchers to study the role of large m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57202fe4a5948aaf1e1567ed54a3b3a6
https://europepmc.org/articles/PMC7001472/
https://europepmc.org/articles/PMC7001472/
Autor:
Peter N. Uchakin, Brenda M Gannon, Sarah E. Abney, Aboagyewaah Oppong-Damoah, Kevin S. Murnane, Bruce E. Blough
Publikováno v:
The FASEB Journal. 34:1-1
Publikováno v:
The FASEB Journal. 32
Autor:
Kevin S. Murnane, Richard Darien Khusial, Cedrick Maceo Daphney, Sarah E. Abney, Peter N. Uchakin, Olga N. Uchakina, Aboagyewaah Oppong-Damoah, Ayman Akil, Lindsey Phillips Lindsey
Publikováno v:
Behav Brain Res
Age-related cognitive decline has been associated with proinflammatory cytokines, yet the precise relationship between cognitive decline and cytokine load remains to be elucidated. β-caryophyllene (BCP) is a cannabinoid receptor 2 (CB2) agonist with